Niva Bupa Health Insurance, India’s third-largest standalone health insurer, is set to launch its IPO from November 6 to November 8, 2024. This ₹2,200 crore IPO includes a fresh issue of ₹800 crore and an Offer for Sale of ₹1,400 crore by Bupa Singapore Holdings and Fettle Tone. Listing on BSE and NSE is expected by November 13. With a Gross Direct Premium Income of ₹5,494 crore in 2024, Niva Bupa achieved a 41.37% CAGR from FY22 to FY24, outpacing the industry’s 21.42% growth rate. The company's profit rose from ₹12.54 crore in 2023 to ₹81.85 crore in 2024, demonstrating robust performance. Peers like Star Health and ICICI Lombard pose significant competition.